Implantable, light-sensitive hydrogel could help treat diabetes

Researchers at Harvard Medical School have created an implantable hydrogel that can be used as a diabetes treatment. When shone with a light, genetically modified cells in the gel produced a compound that triggered insulin secretion. Although still in its very early stages, the scientists are working on a way to make the device smaller by using micro-LED technology and a wireless power receiver, according to a report from New Scientist. As of now, the device is bulky and needs to be connected to an external wire. More

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…